The Dexcom G7 Sensor enlarged next to a photo of Dexcom CEO Jake Leach

Guest interview: “Nerdabetic” talks to Dexcom’s Jake Leach

Dexcom’s G7 is still not approved in the United States, but it’s in limited release in Europe. This week, friend of the show Kamil Armacki, better known as Nerdabetic, interviews Dexcom’s Chief Operating Officer, Jake Leach. Find more about Kamil over at his amazing YouTube Channel here: https://www.youtube.com/c/nerdabetic This podcast is not intended as medical…

A screen shot of a Loop control panel and a women researcher with computer imagery

“I think it’s just the beginning” – A new way to test DIY pump systems from UVA

Researchers at UVA recently published a study called Design and Validation of an Open-Source Closed-Loop Testbed for Artificial Pancreas Systems. They say what they’ve set up here is quote – a valid tool that can be used by the research community to demonstrate the effectiveness of different control algorithms and safety features for APS, automated…

A laptop with the CampViews program showing many CGM numbers is held in front of campers

CampViews: a new way to see every diabetes camper’s CGM data, all at once

It’s that time of year – diabetes camps are in full swing. As remote monitoring technology changes, many camps are adapting as well. There’s a new system that lets camp staff monitor everyone’s CGM, all at once. That’s Sarah Gleich, executive director of the Nevada California Diabetes Association. We’ll find out more about what’s called…

Sernova CEO Philip Toleikis

“This is Becoming a Reality” – Sernova’s Cell Therapy Approach to a Functional T1D Cure

Big news from Sernova, one of the companies hoping that implantable stem cells will be a functional cure for diabetes. They recently announced that the first person in their trials with type 1 is completely off injected or infused insulin – and is making their own. Stacey talks to Dr. Philip Toleikis, Sernova’s president and…

Stacey and Kevin Sayer on Zoom. Kevin holds up a box with G7 on the side

“Dexcom is Preparing for the Future” CEO Kevin Sayer on G7, the international market, competitors and more

Dexcom CEO Kevin Sayer joins Stacey from the American Diabetes Association’s Scientific Sessions with new G7 information, a response to Abbott’s Libre 3 approval, addressing rumors about acquiring another diabetes company and a lot more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care…